These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pre-operative radiotherapy for rectal carcinoma. Peeters K; Kranenbarg EK; van de Velde C Colorectal Dis; 2004 Jul; 6(4):288-9. PubMed ID: 15206976 [No Abstract] [Full Text] [Related]
24. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B; Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107 [TBL] [Abstract][Full Text] [Related]
25. Reduction "by half". The need for standardised surgical technique in studies of radiotherapy for rectal cancer. Wiggers T; van de Velde CH Eur J Surg; 1999 May; 165(5):407-9. PubMed ID: 10391154 [No Abstract] [Full Text] [Related]
26. How safe is adjuvant chemotherapy and radiotherapy for rectal cancer? Chao MW; Tjandra JJ; Gibbs P; McLaughlin S Asian J Surg; 2004 Apr; 27(2):147-61. PubMed ID: 15140670 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of rectal cancer and follow up]. Charúa-Guindic L Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():126-31. PubMed ID: 18277500 [No Abstract] [Full Text] [Related]
30. Chemoradiotherapy for rectal cancer. Ferretti G; Bria E; Mandalà M N Engl J Med; 2005 Feb; 352(5):509-11; author reply 509-11. PubMed ID: 15690594 [No Abstract] [Full Text] [Related]
31. Irradiation with and without razoxane in the treatment of incompletely resected or inoperable recurrent rectal cancer. Results of a small randomized multicenter study. Rhomberg W; Hammer J; Sedlmayer F; Eiter H; Seewald D; Schneider B Strahlenther Onkol; 2007 Jul; 183(7):380-4. PubMed ID: 17609871 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433 [TBL] [Abstract][Full Text] [Related]
33. [Remarks on the update titled: adjuvant treatment of rectal cancer]. Huguier M Gastroenterol Clin Biol; 1997; 21(5):430-2. PubMed ID: 9208021 [No Abstract] [Full Text] [Related]
34. Surgical quality in trials of adjuvant cancer therapy. Hundahl SA J Surg Oncol; 2002 Aug; 80(4):177-80. PubMed ID: 12210030 [No Abstract] [Full Text] [Related]
35. [Preoperative treatment of resectable rectal cancer]. Lasser P Ann Chir; 1998; 52(10):989-92; discussion 993-8. PubMed ID: 9951099 [No Abstract] [Full Text] [Related]
36. [Adjuvant treatment in cancer of the rectum]. Dubois JB Ann Gastroenterol Hepatol (Paris); 1995; 31(2):91-5. PubMed ID: 7618849 [No Abstract] [Full Text] [Related]
37. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature]. Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600 [TBL] [Abstract][Full Text] [Related]
38. Transanal endoscopic microsurgery in early rectal cancer: time for a trial? Suppiah A; Maslekar S; Alabi A; Hartley JE; Monson JR Colorectal Dis; 2008 May; 10(4):314-27; discussion 327-9. PubMed ID: 18190614 [TBL] [Abstract][Full Text] [Related]
39. [Total mesorectal excision: does it make radiotherapy superfluous?]. Rödel C Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S118-20. PubMed ID: 12817343 [No Abstract] [Full Text] [Related]
40. [Advantages of neoadjuvant therapy in rectal neoplasm]. Nano M; Ferronato M; Solej M; D'Amico S G Chir; 2008 May; 29(5):197-202. PubMed ID: 18507953 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]